What it's for (Indications)
- Cholecalciferol (Vitamin D3) is indicated for the prevention and treatment of vitamin D deficiency, a common condition associated with various health issues.
- This high-dose formulation (e.
- g.
- , 200,000 IU) is particularly utilized for rapid repletion in severe vitamin D deficiency states.
- It is also employed in the management of metabolic bone diseases such as rickets, osteomalacia, and as an adjunct in the treatment of osteoporosis, especially when deficiency is identified as a contributing factor.
- Furthermore, it plays a role in the management of hypoparathyroidism to maintain calcium homeostasis and mitigate secondary complications.
- Its therapeutic use extends to situations where natural synthesis or dietary intake of vitamin D is inadequate, thereby supporting overall bone health, immune function, and calcium-phosphate regulation within the body.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage of cholecalciferol must be individualized based on the patient's age, severity of vitamin D deficiency, renal function, and concomitant medical conditions. For severe vitamin D deficiency, high-dose formulations like 200,000 IU are typically administered as a single oral dose or as part of a short-term loading regimen, followed by lower maintenance doses. For instance, a single oral dose of 200,000 IU may be given monthly or less frequently (e.g., once every 3 months) under strict medical supervision to achieve target 25-hydroxyvitamin D levels. It is crucial to regularly monitor serum 25-hydroxyvitamin D and calcium levels during and after high-dose therapy to ensure efficacy and prevent toxicity. The therapeutic window for vitamin D can be narrow, particularly with such potent formulations, necessitating precise dosing, diligent follow-up, and avoidance of self-medication due to the inherent risks of hypervitaminosis D. |
Safety & Warnings
Common Side Effects
- While cholecalciferol is generally well-tolerated at appropriate physiological doses, its high-dose administration, such as 200,000 IU, carries a significant risk of adverse effects, primarily stemming from vitamin D toxicity, also known as hypervitaminosis D.
- The most prominent and clinically significant side effect is hypercalcemia, which can manifest with a range of symptoms including nausea, vomiting, constipation, abdominal pain, anorexia, polyuria, polydipsia, weakness, fatigue, headache, dizziness, and confusion.
- Prolonged and severe hypercalcemia can lead to serious complications such as nephrocalcinosis, nephrolithiasis (kidney stones), renal impairment, and potentially life-threatening cardiac arrhythmias.
- Other less common adverse reactions at therapeutic doses may include hypersensitivity reactions (e.
- g.
- , rash, pruritus) or mild gastrointestinal disturbances.
- Careful monitoring is essential to detect and manage these potential adverse events promptly.
Serious Warnings
- Black Box Warning: **Serious Warnings: Risk of Hypercalcemia and Hypervitaminosis D** Cholecalciferol, particularly in high-dose formulations such as 200,000 IU, carries a significant risk of inducing hypercalcemia and hypervitaminosis D if not administered and monitored precisely. Vitamin D toxicity, characterized by dangerously elevated levels of serum calcium, can lead to severe and potentially irreversible consequences affecting multiple organ systems. These include renal damage (e.g., nephrocalcinosis, nephrolithiasis, chronic kidney disease), cardiovascular complications (e.g., cardiac arrhythmias, hypertension), and widespread soft tissue calcification. Patients and prescribers must be acutely aware of the narrow therapeutic window for high-dose vitamin D. Rigorous monitoring of serum calcium, phosphate, and 25-hydroxyvitamin D levels is imperative both during and after therapy to prevent toxicity. Patients should be thoroughly educated on the symptoms of hypercalcemia (e.g., nausea, vomiting, polyuria, weakness, confusion) and instructed to seek immediate medical attention if these occur. Individualized dosing based on clinical response and laboratory parameters is critical to mitigate these serious risks. This product is not intended for unsupervised self-medication due to these potential hazards.
- Patients receiving cholecalciferol, especially high-dose preparations, require vigilant monitoring due to the potential for serious adverse effects, primarily the development of hypercalcemia and hyperphosphatemia, which can lead to significant organ damage if unmanaged.
- Particular caution is warranted in patients with pre-existing conditions such as impaired renal function, a history of nephrolithiasis, or those with granulomatous diseases like sarcoidosis, as these individuals exhibit increased sensitivity to vitamin D and are at a higher risk of hypercalcemia.
- Concomitant use of thiazide diuretics, calcium supplements, or cardiac glycosides also necessitates careful monitoring due to additive effects on calcium levels or increased risk of cardiotoxicity.
- Patients should be advised to report any symptoms indicative of hypercalcemia promptly.
- Regular assessment of serum calcium, phosphate, and 25-hydroxyvitamin D levels is critical throughout therapy to prevent toxicity and optimize treatment outcomes.
- Avoid excessive sun exposure while on high-dose therapy.
How it Works (Mechanism of Action)
Cholecalciferol (Vitamin D3) is an inert prohormone that undergoes a crucial two-step activation process within the body to exert its biological effects. Initially, it is hydroxylated in the liver by the enzyme 25-hydroxylase to form 25-hydroxyvitamin D (calcifediol). This calcifediol then serves as a substrate for a second hydroxylation step, primarily in the kidneys, catalyzed by the 1-alpha-hydroxylase enzyme, to produce the biologically active form, 1,25-dihydroxyvitamin D (calcitriol). Calcitriol functions as a steroid hormone, regulating calcium and phosphate homeostasis. It acts on target cells in the intestines to promote the absorption of dietary calcium and phosphate, in the bones to facilitate bone mineralization and remodeling by influencing osteoblast and osteoclast activity, and in the kidneys to enhance the reabsorption of calcium and phosphate. Furthermore, vitamin D receptors are found in various other tissues, suggesting broader pleiotropic effects, including immunomodulation, anti-inflammatory properties, and roles in cell growth and differentiation, contributing to overall physiological well-being.